{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:21:27Z","timestamp":1791994887362,"version":"4.4.0"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1093\/jpids\/pit077","type":"journal-article","created":{"date-parts":[[2014,1,17]],"date-time":"2014-01-17T21:24:40Z","timestamp":1389993880000},"page":"132-145","source":"Crossref","is-referenced-by-count":45,"title":["Rifapentine Pharmacokinetics and Tolerability in Children and Adults Treated Once Weekly With Rifapentine and Isoniazid for Latent Tuberculosis Infection"],"prefix":"10.1093","volume":"3","author":[{"given":"Marc","family":"Weiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radojka M.","family":"Savic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R. Mac","family":"Kenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Wing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Peloquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Engle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Bliven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Prihoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A. L.","family":"Gelfond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel A.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Abdel-Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory L.","family":"Kearns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Burman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.","family":"Sterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Elsa","family":"Villarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,1,16]]},"reference":[{"key":"key\n\t\t\t\t20170523190750_PIT077C1","article-title":"WHO Report 2009","author":"Global tuberculosis control\u2014epidemiology, strategy, financing"},{"key":"key\n\t\t\t\t20170523190750_PIT077C2","first-page":"259","article-title":"The burden of childhood tuberculosis and the accuracy of routine surveillance data in a high burden setting","volume":"10","author":"Marais","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20170523190750_PIT077C3","article-title":"A research agenda for childhood tuberculosis: improving the management of childhood tuberculosis within national tuberculosis programmes: research priorities based on a literature review","author":"World Health Organization","year":"2007"},{"key":"key\n\t\t\t\t20170523190750_PIT077C4","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170523190750_PIT077C5","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1164\/rccm.200512-1953OC","article-title":"Weekly rifapentine\/isoniazid or daily rifampin\/pyrazinamide for latent tuberculosis in household contacts","volume":"173","author":"Schechter","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20170523190750_PIT077C6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1005136","article-title":"New regimens to prevent tuberculosis in adults with HIV infection","volume":"365","author":"Martinson","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170523190750_PIT077C7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/01.inf.0000214963.55217.9c","article-title":"Pharmacokinetics of rifapentine in children","volume":"25","author":"Blake","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170523190750_PIT077C8","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1164\/rccm.200311-1612OC","article-title":"Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy","volume":"169","author":"Weiner","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20170523190750_PIT077C9","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/00006454-199910000-00009","article-title":"Rifapentine pharmacokinetics in adolescents","volume":"18","author":"Marshall","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170523190750_PIT077C10","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1164\/rccm.200208-951OC","article-title":"Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine","volume":"167","author":"Weiner","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20170523190750_PIT077C11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1086\/520011","article-title":"Stability of antituberculosis drugs mixed in food","volume":"45","author":"Peloquin","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170523190750_PIT077C12","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1128\/AAC.00554-08","article-title":"Repeated administration of high-dose intermittent rifapentine reduces rifapentine and moxi\ufb02oxacin plasma concentrations","volume":"52","author":"Dooley","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170523190750_PIT077C13","article-title":"Priftin (rifapentine) tablets: full prescribing information (package insert), 2010","author":"Sanofi-aventis U.S. LLC"},{"key":"key\n\t\t\t\t20170523190750_PIT077C14","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1128\/AAC.43.5.1230","article-title":"Pharmacokinetics of rifapentine in subjects seropositive for the human immunodeficiency virus: a phase I study","volume":"43","author":"Keung","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170523190750_PIT077C15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0924-8579(94)90054-X","article-title":"Comparison of Chinese and Western rifapentines and improvement of bioavailability by prior taking of various meals","volume":"3","author":"Chan","year":"1994","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170523190750_PIT077C16","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1128\/AAC.00345-10","article-title":"Effect of four different meals types on the population pharmacokinetics of single dose rifapentine in healthy male volunteers","volume":"54","author":"Zvada","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170523190750_PIT077C17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/jac\/46.4.565","article-title":"Activity of rifapentine and its metabolite 25-O-desacetylrifapentine compared with rifampicin and rifabutin against Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis and M. bovis BCG","volume":"46","author":"Rastogi","year":"2000","journal-title":"J Antimicrobial Chemother"},{"key":"key\n\t\t\t\t20170523190750_PIT077C18","first-page":"1323","article-title":"Tolerability among children of three months of once-weekly rifapentine+INH (3HP) vs 9 months of daily INH (9H) for treatment of latent tuberculosis infection: the PREVENT TB Study (TBTC Study 26\/ACTG 5259)","volume":"182","author":"Villarino","year":"2012","journal-title":"Program and abstracts of IDWeek"},{"key":"key\n\t\t\t\t20170523190750_PIT077C19","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jpba.2006.03.004","article-title":"Study of the interaction between rifapentine and isoniazid under acid conditions","volume":"41","author":"Prasad","year":"2006","journal-title":"J Pharm Biomed Anal"},{"key":"key\n\t\t\t\t20170523190750_PIT077C20","article-title":"Population pharmacokinetics of rifapentine and its active metabolite in healthy volunteers: nonlinearities in clearance and bioavailability [abstract]","author":"Savic","journal-title":"Program and abstracts of the 4th International Workshop on Clinical Pharmacology of TB Drugs (Chicago), 2011"},{"key":"key\n\t\t\t\t20170523190750_PIT077C21","article-title":"Percentile Data Files with LMS Values","author":"Centers for Disease Control and Prevention"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jpids\/article-pdf\/3\/2\/132\/17487874\/pit077.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T15:46:34Z","timestamp":1565106394000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article-lookup\/doi\/10.1093\/jpids\/pit077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,16]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,1,16]]},"published-print":{"date-parts":[[2014,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/pit077","relation":{},"ISSN":["2048-7207","2048-7193"],"issn-type":[{"value":"2048-7207","type":"electronic"},{"value":"2048-7193","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1,16]]}}}